In response to the financial crisis driven by the coronavirus disease 2019 (COVID-19) pandemic, drug manufacturers are aiming to increase access to insulin products.
Jennifer Nessel, Assistant Editors
Advertisement
Articles by Jennifer Nessel, Assistant Editors
Advertisement
Latest Updated Articles
Manufacturers Launch Programs to Allow Greater Access to Insulin in Response to COVID-19Published: April 9th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
4
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
5
